The real culprit in systemic lupus erythematosus: Abnormal epigenetic regulation

International Journal of Molecular Sciences

Volumn 16, Issue 5, 2015, Pages 11013-11033

  Wu, Haijing ^a   Zhao, Ming ^a   Chang, Christopher ^b   Lu, Qianjin ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

DNA methylation; Epigenetics; Histone modification; MicroRNA; SLE

Indexed keywords

HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE; INTERFERON; MICRORNA; HISTONE; HISTONE DEACETYLASE INHIBITOR;

3' UNTRANSLATED REGION; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CPG ISLAND; DENDRITIC CELL; DNA METHYLATION; DOWN REGULATION; EPIGENETICS; GENE EXPRESSION; HELPER CELL; HISTONE MODIFICATION; HUMAN; MAJOR HISTOCOMPATIBILITY COMPLEX; PATHOGENESIS; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; UPREGULATION; CHEMISTRY; GENETIC EPIGENESIS; GENETICS; IMMUNOLOGY; LUPUS ERYTHEMATOSUS, SYSTEMIC; METABOLISM; PATHOLOGY; T LYMPHOCYTE;

B-LYMPHOCYTES; DNA METHYLATION; EPIGENESIS, GENETIC; HISTONE DEACETYLASE INHIBITORS; HISTONES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICRORNAS; T-LYMPHOCYTES;

EID: 84929346691     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms160511013     Document Type: Review

References (131)

1. D’Cruz, D.P.; Khamashta, M.A.; Hughes, G.R. Systemic lupus erythematosus. Lancet 2007, 369, 587–596.
2. Danchenko, N.; Satia, J.A.; Anthony, M.S. Epidemiology of systemic lupus erythematosus: A comparison of worldwide disease burden. Lupus 2006, 15, 308–318.
3. O’Neill, S.; Cervera, R. Systemic lupus erythematosus. Clin. Rheumatol. 2010, 24, 841–855.
4. Tan, E.M.; Kunkel, H.G. Characteristics of a soluble nuclear antigen precipitating with sera of patients with systemic lupus erythematosus. J. Immunol. 1966, 96, 464–471.
5. Takeno, M.; Nagafuchi, H.; Kaneko, S.; Wakisaka, S.; Oneda, K.; Takeba, Y.; Yamashita, N.; Suzuki, N.; Kaneoka, H.; Sakane, T. Autoreactive T cell clones from patients with systemic lupus erythematosus support polyclonal autoantibody production. J. Immunol. 1997, 158, 3529–3538.
6. Santulli-Marotto, S.; Retter, M.W.; Gee, R.; Mamula, M.J.; Clarke, S.H. Autoreactive B cell regulation: Peripheral induction of developmental arrest by lupus-associated autoantigens. Immunity 1998, 8, 209–219.
7. Gatto, M.; Zen, M.; Ghirardello, A.; Bettio, S.; Bassi, N.; Iaccarino, L.; Punzi, L.; Doria, A. Emerging and critical issues in the pathogenesis of lupus. Autoimmun. Rev. 2013, 12, 523–536.
8. Joseph, F.G.; Lammie, G.A.; Scolding, N.J. CNS lupus: A study of 41 patients. Neurology 2007, 69, 644–654.
9. Kuhn, A.; Ruland, V.; Bonsmann, G. Cutaneous lupus erythematosus: Update of therapeutic options part II. J. Am. Acad. Dermatol. 2011, 65, e195–e213.
10. Gabba, A.; Piga, M.; Vacca, A.; Porru, G.; Garau, P.; Cauli, A.; Mathieu, A. Joint and tendon involvement in systemic lupus erythematosus: An ultrasound study of hands and wrists in 108 patients. Rheumatology 2012, 51, 2278–2285.
11. Wanitpongpun, C.; Teawtrakul, N.; Mahakkanukrauh, A.; Siritunyaporn, S.; Sirijerachai, C.; Chansung, K. Bone marrow abnormalities in systemic lupus erythematosus with peripheral cytopenia. Clin. Exp. Rheumatol. 2012, 30, 825–829.
12. Jeffries, M.A.; Sawalha, A.H. Epigenetics in systemic lupus erythematosus: Leading the way for specific therapeutic agents. Int. J. Clin. Rheumatol. 2011, 6, 423–439.
13. Rhodes, B.; Vyse, T.J. The genetics of SLE: An update in the light of genome-wide association studies. Rheumatology 2008, 47, 1603–1611.
14. Quddus, J.; Johnson, K.J.; Gavalchin, J.; Amento, E.P.; Chrisp, C.E.; Yung, R.L.; Richardson, B.C. Treating activated CD4+ T cells with either of two distinct DNA methyltransferase inhibitors, 5-azacytidine or procainamide, is sufficient to cause a lupus-like disease in syngeneic mice. J. Clin. Investig. 1993, 92, 38–53.
15. Bernstein, B.E.; Meissner, A.; Lander, E.S. The mammalian epigenome. Cell 2007, 128, 669–681.
16. Denis, H.; Ndlovu, M.N.; Fuks, F. Regulation of mammalian DNA methyltransferases: A route to new mechanisms. EMBO Rep. 2011, 12, 647–656.
17. Bird, A. DNA methylation patterns and epigenetic memory. Genes Dev. 2002, 16, 6–21.
18. Cannat, A.; Seligmann, M. Induction by isoniazid and hydrallazine of antinuclear factors in mice. Clin. Exp. Immunol. 1968, 3, 99–105.
19. Javierre, B.M.; Fernandez, A.F.; Richter, J.; Al-Shahrour, F.; Martin-Subero, J.I.; Rodriguez-Ubreva, J.; Berdasco, M.; Fraga, M.F.; O’Hanlon, T.P.; Rider, L.G., et al. Changes in the pattern of DNA methylation associate with twin discordance in systemic lupus erythematosus. Genome Res. 2010, 20, 170–179.
20. Zhao, M.; Liu, S.; Luo, S.; Wu, H.; Tang, M.; Cheng, W.; Zhang, Q.; Zhang, P.; Yu, X.; Xia, Y., et al. DNA methylation and mRNA and microRNA expression of sle CD4+ T cells correlate with disease phenotype. J. Autoimmun. 2014, 54, 127–136.
21. Murphy, K.M.; Stockinger, B. Effector T cell plasticity: Flexibility in the face of changing circumstances. Nat. Immunol. 2010, 11, 674–680.
22. Palmer, M.T.; Weaver, C.T. Autoimmunity: Increasing suspects in the CD4+ T cell lineup. Nat. Immunol. 2010, 11, 36–40.
23. Chan, R.W.; Lai, F.M.; Li, E.K.; Tam, L.S.; Chow, K.M.; Li, P.K.; Szeto, C.C. Imbalance of Th1/Th2 transcription factors in patients with lupus nephritis. Rheumatology 2006, 45, 951–957.
24. Yang, J.; Chu, Y.; Yang, X.; Gao, D.; Zhu, L.; Yang, X.; Wan, L.; Li, M. Th17 and natural Treg cell population dynamics in systemic lupus erythematosus. Arthritis Rheum. 2009, 60, 1472–1483.
25. Feng, X.; Wang, D.; Chen, J.; Lu, L.; Hua, B.; Li, X.; Tsao, B.P.; Sun, L. Inhibition of aberrant circulating Tfh cell proportions by corticosteroids in patients with systemic lupus erythematosus. PLoS ONE 2012, 7, e51982.
26. Choi, J.Y.; Ho, J.H.; Pasoto, S.G.; Bunin, V.; Kim, S.; Carrasco, S.; Borba, E.F.; Goncalves, C.R.; Costa, P.R.; Kallas, E.G., et al. Circulating follicular helper-like T cells in systemic lupus erythematosus: Association with disease activity. Arthritis Rheumatol. 2015, 67, 988–999.
27. Richardson, B.; Scheinbart, L.; Strahler, J.; Gross, L.; Hanash, S.; Johnson, M. Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum. 1990, 33, 1665–1673.
28. Cornacchia, E.; Golbus, J.; Maybaum, J.; Strahler, J.; Hanash, S.; Richardson, B. Hydralazine and procainamide inhibit T cell DNA methylation and induce autoreactivity. J. Immunol. 1988, 140, 2197–2200.
29. Ballas, Z.K. The use of 5-azacytidine to establish constitutive interleukin 2-producing clones of the EL4 thymoma. J. Immunol. 1984, 133, 7–9.
30. Agarwal, S.; Rao, A. Modulation of chromatin structure regulates cytokine gene expression during T cell differentiation. Immunity 1998, 9, 765–775.
31. Bix, M.; Locksley, R.M. Independent and epigenetic regulation of the interleukin-4 alleles in CD4+ T cells. Science 1998, 281, 1352–1354.
32. Lal, G.; Zhang, N.; van der Touw, W.; Ding, Y.; Ju, W.; Bottinger, E.P.; Reid, S.P.; Levy, D.E.; Bromberg, J.S. Epigenetic regulation of Foxp3 expression in regulatory T cells by DNA methylation. J. Immunol. 2009, 182, 259–273.
33. Xu, J.; Zhang, G.; Cheng, Y.; Chen, B.; Dong, Y.; Li, L.; Xu, L.; Xu, X.; Lu, Z.; Wen, J. Hypomethylation of the HTR1A promoter region and high expression of HTR1A in the peripheral blood lymphocytes of patients with systemic lupus erythematosus. Lupus 2011, 20, 678–689.
34. Lu, Q.; Kaplan, M.; Ray, D.; Ray, D.; Zacharek, S.; Gutsch, D.; Richardson, B. Demethylation of ITGAL (CD11a) regulatory sequences in systemic lupus erythematosus. Arthritis Rheum. 2002, 46, 1282–1291.
35. Zhao, M.; Sun, Y.; Gao, F.; Wu, X.; Tang, J.; Yin, H.; Luo, Y.; Richardson, B.; Lu, Q. Epigenetics and SLE: RFX1 downregulation causes CD11a and CD70 overexpression by altering epigenetic modifications in lupus CD4+ T cells. J. Autoimmun. 2010, 35, 58–69.
36. Zhao, M.; Wu, X.; Zhang, Q.; Luo, S.; Liang, G.; Su, Y.; Tan, Y.; Lu, Q. RFX1 regulates CD70 and CD11a expression in lupus T cells by recruiting the histone methyltransferase SUV39H1. Arthritis Res. Ther. 2010, 12, R227.
37. Richardson, B. Primer: Epigenetics of autoimmunity. Nat. Clin. Pract. Rheumatol. 2007, 3, 521–527.
38. Renaudineau, Y.; Youinou, P. Epigenetics and autoimmunity, with special emphasis on methylation. Keio J. Med. 2011, 60, 10–16.
39. Nagafuchi, H.; Shimoyama, Y.; Kashiwakura, J.; Takeno, M.; Sakane, T.; Suzuki, N. Preferential expression of B7.2 (CD86), but not B7.1 (CD80), on B cells induced by CD40/CD40L interaction is essential for anti-DNA autoantibody production in patients with systemic lupus erythematosus. Clin. Exp. Rheumatol. 2003, 21, 71–77.
40. Li, Y.; Zhao, M.; Yin, H.; Gao, F.; Wu, X.; Luo, Y.; Zhao, S.; Zhang, X.; Su, Y.; Hu, N., et al. Overexpression of the growth arrest and DNA damage-induced 45α gene contributes to autoimmunity by promoting DNA demethylation in lupus T cells. Arthritis Rheum. 2010, 62, 1438–1447.
41. Li, Y.; Huang, C.; Zhao, M.; Liang, G.; Xiao, R.; Yung, S.; Chan, T.M.; Lu, Q. A possible role of HMGB1 in DNA demethylation in CD4+ T cells from patients with systemic lupus erythematosus. Clin. Dev. Immunol. 2013, 2013, 206298.
42. Coit, P.; Jeffries, M.; Altorok, N.; Dozmorov, M.G.; Koelsch, K.A.; Wren, J.D.; Merrill, J.T.; McCune, W.J.; Sawalha, A.H. Genome-wide DNA methylation study suggests epigenetic accessibility and transcriptional poising of interferon-regulated genes in naive CD4+ T cells from lupus patients. J. Autoimmun. 2013, 43, 78–84.
43. Liu, Y.; Chen, Y.; Richardson, B. Decreased DNA methyltransferase levels contribute to abnormal gene expression in “senescent” CD4+CD28− T cells. Clin. Immunol. 2009, 132, 257–265.
44. Zhao, M.; Tang, J.; Gao, F.; Wu, X.; Liang, Y.; Yin, H.; Lu, Q. Hypomethylation of IL-10 and IL-13 promoters in CD4+ T cells of patients with systemic lupus erythematosus. J. Biomed. Biotechnol. 2010, 2010, 931018.
45. Deng, C.; Lu, Q.; Zhang, Z.; Rao, T.; Attwood, J.; Yung, R.; Richardson, B. Hydralazine may induce autoimmunity by inhibiting extracellular signal-regulated kinase pathway signaling. Arthritis Rheum. 2003, 48, 746–756.
46. Gorelik, G.; Fang, J.Y.; Wu, A.; Sawalha, A.H.; Richardson, B. Impaired T cell protein kinase Cδ activation decreases ERK pathway signaling in idiopathic and hydralazine-induced lupus. J. Immunol. 2007, 179, 5553–5563.
47. Gorelik, G.; Sawalha, A.H.; Patel, D.; Johnson, K.; Richardson, B. T cell PKCδ kinase inactivation induces lupus-like autoimmunity in mice. Clin. Immunol. 2015, 158, 193–203.
48. Miyamoto, A.; Nakayama, K.; Imaki, H.; Hirose, S.; Jiang, Y.; Abe, M.; Tsukiyama, T.; Nagahama, H.; Ohno, S.; Hatakeyama, S., et al. Increased proliferation of B cells and auto-immunity in mice lacking protein kinase Cδ. Nature 2002, 416, 865–869.
49. Mecklenbrauker, I.; Saijo, K.; Zheng, N.Y.; Leitges, M.; Tarakhovsky, A. Protein kinase Cδ controls self-antigen-induced B cell tolerance. Nature 2002, 416, 860–865.
50. Sawalha, A.H.; Jeffries, M.; Webb, R.; Lu, Q.; Gorelik, G.; Ray, D.; Osban, J.; Knowlton, N.; Johnson, K.; Richardson, B. Defective T cell ERK signaling induces interferon-regulated gene expression and overexpression of methylation-sensitive genes similar to lupus patients. Genes Immun. 2008, 9, 368–378.
51. Gorelik, G.J.; Yarlagadda, S.; Patel, D.R.; Richardson, B.C. Protein kinase Cδ oxidation contributes to ERK inactivation in lupus T cells. Arthritis Rheum. 2012, 64, 2964–2974.
52. Ross, S.A.; Poirier, L. Proceedings of the trans-HHS workshop: Diet, DNA methylation processes and health. J. Nutr. 2002, 132, 2329S–2332S.
53. Somers, E.C.; Richardson, B.C. Environmental exposures, epigenetic changes and the risk of lupus. Lupus 2014, 23, 568–576.
54. Danbara, M.; Kameyama, K.; Higashihara, M.; Takagaki, Y. DNA methylation dominates transcriptional silencing of Pax5 in terminally differentiated B cell lines. Mol. Immunol. 2002, 38, 1161–1166.
55. Amaravadi, L.; Klemsz, M.J. DNA methylation and chromatin structure regulate PU.1 expression. DNA Cell Biol. 1999, 18, 875–884.
56. Walter, K.; Bonifer, C.; Tagoh, H. Stem cell-specific epigenetic priming and B cell-specific transcriptional activation at the mouse CD19 locus. Blood 2008, 112, 1673–1682.
57. Garaud, S.; le Dantec, C.; Jousse-Joulin, S.; Hanrotel-Saliou, C.; Saraux, A.; Mageed, R.A.; Youinou, P.; Renaudineau, Y. IL-6 modulates CD5 expression in B cells from patients with lupus by regulating DNA methylation. J. Immunol. 2009, 182, 5623–5632.
58. Fali, T.; Le Dantec, C.; Thabet, Y.; Jousse, S.; Hanrotel, C.; Youinou, P.; Brooks, W.H.; Perl, A.; Renaudineau, Y. DNA methylation modulates HRES1/p28 expression in B cells from patients with lupus. Autoimmunity 2014, 47, 265–271.
59. Mazari, L.; Ouarzane, M.; Zouali, M. Subversion of B lymphocyte tolerance by hydralazine, a potential mechanism for drug-induced lupus. Proc. Natl. Acad. Sci. USA 2007, 104, 6317–6322.
60. Fraenkel, S.; Mostoslavsky, R.; Novobrantseva, T.I.; Pelanda, R.; Chaudhuri, J.; Esposito, G.; Jung, S.; Alt, F.W.; Rajewsky, K.; Cedar, H., et al. Allelic “choice” governs somatic hypermutation in vivo at the immunoglobulin κ-chain locus. Nat. Immunol. 2007, 8, 715–722.
61. Giambra, V.; Volpi, S.; Emelyanov, A.V.; Pflugh, D.; Bothwell, A.L.; Norio, P.; Fan, Y.; Ju, Z.; Skoultchi, A.I.; Hardy, R.R., et al. Pax5 and linker histone H1 coordinate DNA methylation and histone modifications in the 3' regulatory region of the immunoglobulin heavy chain locus. Mol. Cell. Biol. 2008, 28, 6123–6133.
62. Chow, J.; Heard, E. X inactivation and the complexities of silencing a sex chromosome. Curr. Opin. Cell Biol. 2009, 21, 359–366.
63. Biermann, M.H.; Veissi, S.; Maueroder, C.; Chaurio, R.; Berens, C.; Herrmann, M.; Munoz, L.E. The role of dead cell clearance in the etiology and pathogenesis of systemic lupus erythematosus: Dendritic cells as potential targets. Expert Rev. Clin. Immunol. 2014, 10, 1151–1164.
64. Kis-Toth, K.; Tsokos, G.C. Dendritic cell function in lupus: Independent contributors or victims of aberrant immune regulation. Autoimmunity 2010, 43, 121–130.
65. Chan, V.S.; Nie, Y.J.; Shen, N.; Yan, S.; Mok, M.Y.; Lau, C.S. Distinct roles of myeloid and plasmacytoid dendritic cells in systemic lupus erythematosus. Autoimmun. Rev. 2012, 11, 890–897.
66. Zouali, M. Epigenetics in lupus. Ann. N. Y. Acad. Sci. 2011, 1217, 154–165.
67. Lei, W.; Luo, Y.; Lei, W.; Luo, Y.; Yan, K.; Zhao, S.; Li, Y.; Qiu, X.; Zhou, Y.; Long, H., et al. Abnormal DNA methylation in CD4+ T cells from patients with systemic lupus erythematosus, systemic sclerosis, and dermatomyositis. Scand. J. Rheumatol. 2009, 38, 369–374.
68. Wang, G.S.; Zhang, M.; Li, X.P.; Zhang, H.; Chen, W.; Kan, M.; Wang, Y.M. Ultraviolet B exposure of peripheral blood mononuclear cells of patients with systemic lupus erythematosus inhibits DNA methylation. Lupus 2009, 18, 1037–1044.
69. Lu, Q.; Wu, A.; Richardson, B.C. Demethylation of the same promoter sequence increases CD70 expression in lupus T cells and T cells treated with lupus-inducing drugs. J. Immunol. 2005, 174, 6212–6219.
70. Singer, N.G.; Richardson, B.C.; Powers, D.; Hooper, F.; Lialios, F.; Endres, J.; Bott, C.M.; Fox, D.A. Role of the CD6 glycoprotein in antigen-specific and autoreactive responses of cloned human T lymphocytes. Immunology 1996, 88, 537–543.
71. Lu, Q.; Wu, A.; Tesmer, L.; Ray, D.; Yousif, N.; Richardson, B. Demethylation of CD40LG on the inactive X in T cells from women with lupus. J. Immunol. 2007, 179, 6352–6358.
72. Sunahori, K.; Juang, Y.T.; Kyttaris, V.C.; Tsokos, G.C. Promoter hypomethylation results in increased expression of protein phosphatase 2A in T cells from patients with systemic lupus erythematosus. J. Immunol. 2011, 186, 4508–4517.
73. Nakkuntod, J.; Avihingsanon, Y.; Mutirangura, A.; Hirankarn, N. Hypomethylation of line-1 but not alu in lymphocyte subsets of systemic lupus erythematosus patients. Clin. Chim. Acta Int. J. Clin. Chem. 2011, 412, 1457–1461.
74. Rothbart, S.B.; Strahl, B.D. Interpreting the language of histone and DNA modifications. Biochim. Biophys. Acta 2014, 1839, 627–643.
75. Peserico, A.; Simone, C. Physical and functional HAT/HDAC interplay regulates protein acetylation balance. J. Biomed. Biotechnol. 2011, 2011, 371832.
76. Black, J.C.; van Rechem, C.; Whetstine, J.R. Histone lysine methylation dynamics: Establishment, regulation, and biological impact. Mol. Cell 2012, 48, 491–507.
77. Hu, N.; Qiu, X.; Luo, Y.; Yuan, J.; Li, Y.; Lei, W.; Zhang, G.; Zhou, Y.; Su, Y.; Lu, Q. Abnormal histone modification patterns in lupus CD4+ T cells. J. Rheumatol. 2008, 35, 804–810.
78. Zhou, Y.; Qiu, X.; Luo, Y.; Yuan, J.; Li, Y.; Zhong, Q.; Zhao, M.; Lu, Q. Histone modifications and methyl-CpG-binding domain protein levels at the TNFSF7 (CD70) promoter in sle CD4+ T cells. Lupus 2011, 20, 1365–1371.
79. Nambiar, M.P.; Warke, V.G.; Fisher, C.U.; Tsokos, G.C. Effect of trichostatin a on human T cells resembles signaling abnormalities in T cells of patients with systemic lupus erythematosus: A new mechanism for TCR ζ chain deficiency and abnormal signaling. J. Cell. Biochem. 2002, 85, 459–469.
80. Hedrich, C.M.; Tsokos, G.C. Epigenetic mechanisms in systemic lupus erythematosus and other autoimmune diseases. Trends Mol. Med. 2011, 17, 714–724.
81. Dai, Y.; Zhang, L.; Hu, C.; Zhang, Y. Genome-wide analysis of histone H3 lysine 4 trimethylation by chip-chip in peripheral blood mononuclear cells of systemic lupus erythematosus patients. Clin. Exp. Rheumatol. 2010, 28, 158–168.
82. Zhang, Z.; Song, L.; Maurer, K.; Petri, M.A.; Sullivan, K.E. Global H4 acetylation analysis by chip-chip in systemic lupus erythematosus monocytes. Genes Immun. 2010, 11, 124–133.
83. Apostolidis, S.A.; Rauen, T.; Hedrich, C.M.; Tsokos, G.C.; Crispin, J.C. Protein phosphatase 2A enables expression of interleukin 17 (IL-17) through chromatin remodeling. J. Biol. Chem. 2013, 288, 26775–26784.
84. Hedrich, C.M.; Rauen, T.; Apostolidis, S.A.; Grammatikos, A.P.; Rodriguez Rodriguez, N.; Ioannidis, C.; Kyttaris, V.C.; Crispin, J.C.; Tsokos, G.C. Stat3 promotes IL-10 expression in lupus T cells through trans-activation and chromatin remodeling. Proc. Natl. Acad. Sci. USA 2014, 111, 13457–13462.
85. Sullivan, K.E.; Suriano, A.; Dietzmann, K.; Lin, J.; Goldman, D.; Petri, M.A. The TNFα locus is altered in monocytes from patients with systemic lupus erythematosus. Clin. Immunol. 2007, 123, 74–81.
86. Hu, N.; Long, H.; Zhao, M.; Yin, H.; Lu, Q. Aberrant expression pattern of histone acetylation modifiers and mitigation of lupus by SIRT1-siRNA in MRL/lpr mice. Scand. J. Rheumatol. 2009, 38, 464–471.
87. Mishra, N.; Reilly, C.M.; Brown, D.R.; Ruiz, P.; Gilkeson, G.S. Histone deacetylase inhibitors modulate renal disease in the MRL-lpr/lpr mouse. J. Clin. Investig. 2003, 111, 539–552.
88. Farh, K.K.; Marson, A.; Zhu, J.; Kleinewietfeld, M.; Housley, W.J.; Beik, S.; Shoresh, N.; Whitton, H.; Ryan, R.J.; Shishkin, A.A., et al. Genetic and epigenetic fine mapping of causal autoimmune disease variants. Nature 2015, 518, 337–343.
89. Chen, C.Z.; Li, L.; Lodish, H.F.; Bartel, D.P. MicroRNAs modulate hematopoietic lineage differentiation. Science 2004, 303, 83–86.
90. Fabian, M.R.; Sonenberg, N.; Filipowicz, W. Regulation of mRNA translation and stability by microRNAs. Annu. Rev. Biochem. 2010, 79, 351–379.
91. Inui, M.; Martello, G.; Piccolo, S. MicroRNA control of signal transduction. Nat. Rev. Mol. Cell Biol. 2010, 11, 252–263.
92. Bartel, D.P. MicroRNAs: Target recognition and regulatory functions. Cell 2009, 136, 215–233.
93. Baltimore, D.; Boldin, M.P.; O’Connell, R.M.; Rao, D.S.; Taganov, K.D. MicroRNAs: New regulators of immune cell development and function. Nat. Immunol. 2008, 9, 839–845.
94. O’Connell, R.M.; Rao, D.S.; Chaudhuri, A.A.; Baltimore, D. Physiological and pathological roles for microRNAs in the immune system. Nat. Rev. Immunol. 2010, 10, 111–122.
95. Yan, S.; Yim, L.Y.; Lu, L.; Lau, C.S.; Chan, V.S. MicroRNA regulation in systemic lupus erythematosus pathogenesis. Immune Netw. 2014, 14, 138–148.
96. Zhao, S.; Wang, Y.; Liang, Y.; Zhao, M.; Long, H.; Ding, S.; Yin, H.; Lu, Q. MicroRNA-126 regulates DNA methylation in CD4+ T cells and contributes to systemic lupus erythematosus by targeting DNA methyltransferase 1. Arthritis Rheum. 2011, 63, 1376–1386.
97. Pan, W.; Zhu, S.; Yuan, M.; Cui, H.; Wang, L.; Luo, X.; Li, J.; Zhou, H.; Tang, Y.; Shen, N. MicroRNA-21 and microRNA-148a contribute to DNA hypomethylation in lupus CD4+ T cells by directly and indirectly targeting DNA methyltransferase 1. J. Immunol. 2010, 184, 6773–6781.
98. Qin, H.; Zhu, X.; Liang, J.; Wu, J.; Yang, Y.; Wang, S.; Shi, W.; Xu, J. MicroRNA-29b contributes to DNA hypomethylation of CD4+ T cells in systemic lupus erythematosus by indirectly targeting DNA methyltransferase 1. J. Dermatol. Sci. 2013, 69, 61–67.
99. Stagakis, E.; Bertsias, G.; Verginis, P.; Nakou, M.; Hatziapostolou, M.; Kritikos, H.; Iliopoulos, D.; Boumpas, D.T. Identification of novel microRNA signatures linked to human lupus disease activity and pathogenesis: miR-21 regulates aberrant T cell responses through regulation of PDCD4 expression. Ann. Rheum. Dis. 2011, 70, 1496–1506.
100. Ding, S.; Liang, Y.; Zhao, M.; Liang, G.; Long, H.; Zhao, S.; Wang, Y.; Yin, H.; Zhang, P.; Zhang, Q., et al. Decreased microRNA-142-3p/5p expression causes CD4+ T cell activation and B cell hyperstimulation in systemic lupus erythematosus. Arthritis Rheum. 2012, 64, 2953–2963.
101. Fan, W.; Liang, D.; Tang, Y.; Qu, B.; Cui, H.; Luo, X.; Huang, X.; Chen, S.; Higgs, B.W.; Jallal, B., et al. Identification of microRNA-31 as a novel regulator contributing to impaired interleukin-2 production in T cells from patients with systemic lupus erythematosus. Arthritis Rheum. 2012, 64, 3715–3725.
102. Tang, Q.; Yang, Y.; Zhao, M.; Liang, G.; Wu, H.; Liu, Q.; Xie, Y.; Li, D.; Dai, Y.; Yung, S., et al. Mycophenolic acid upregulates miR-142-3p/5p and miR-146a in lupus CD4+ T cells. Lupus 2015, doi:10.1177/0961203315570685.
103. Liu, Y.; Dong, J.; Mu, R.; Gao, Y.; Tan, X.; Li, Y.; Li, Z.; Yang, G. MicroRNA-30a promotes B cell hyperactivity in patients with systemic lupus erythematosus by direct interaction with Lyn. Arthritis Rheum. 2013, 65, 1603–1611.
104. Dorsett, Y.; McBride, K.M.; Jankovic, M.; Gazumyan, A.; Thai, T.H.; Robbiani, D.F.; di Virgilio, M.; Reina San-Martin, B.; Heidkamp, G.; Schwickert, T.A., et al. MicroRNA-155 suppresses activation-induced cytidine deaminase-mediated Myc-Igh translocation. Immunity 2008, 28, 630–638.
105. De Yebenes, V.G.; Belver, L.; Pisano, D.G.; Gonzalez, S.; Villasante, A.; Croce, C.; He, L.; Ramiro, A.R. miR-181b negatively regulates activation-induced cytidine deaminase in B cells. J. Exp. Med. 2008, 205, 2199–2206.
106. Yuan, Y.; Kasar, S.; Underbayev, C.; Vollenweider, D.; Salerno, E.; Kotenko, S.V.; Raveche, E. Role of microRNA-15a in autoantibody production in interferon-augmented murine model of lupus. Mol. Immunol. 2012, 52, 61–70.
107. Luo, S.; Liu, Y.; Liang, G.; Zhao, M.; Wu, H.; Liang, Y.; Qiu, X.; Tan, Y.; Dai, Y.; Yung, S., et al. The role of microRNA-1246 in the regulation of B cell activation and the pathogenesis of systemic lupus erythematosus. Clin. Epigenet. 2015, 7, 24.
108. Baechler, E.C.; Batliwalla, F.M.; Karypis, G.; Gaffney, P.M.; Ortmann, W.A.; Espe, K.J.; Shark, K.B.; Grande, W.J.; Hughes, K.M.; Kapur, V., et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc. Natl. Acad. Sci. USA 2003, 100, 2610–2615.
109. Dominguez-Gutierrez, P.R.; Ceribelli, A.; Satoh, M.; Sobel, E.S.; Reeves, W.H.; Chan, E.K. Positive correlation of Stat1 and miR-146a with anemia in patients with systemic lupus erythematosus. J. Clin. Immunol. 2014, 34, 171–180.
110. Ji, J.D.; Cha, E.S.; Lee, W.J. Association of miR-146a polymorphisms with systemic lupus erythematosus: A meta-analysis. Lupus 2014, 23, 1023–1030.
111. Lee, Y.H.; Bae, S.C. The miR-146a polymorphism and susceptibility to systemic lupus erythematosus and rheumatoid arthritis: A meta-analysis. Z. Rheumatol. 2014, 74, 153–156.
112. Zhou, H.; Huang, X.; Cui, H.; Luo, X.; Tang, Y.; Chen, S.; Wu, L.; Shen, N. miR-155 and its star-form partner miR-155* cooperatively regulate type I interferon production by human plasmacytoid dendritic cells. Blood 2010, 116, 5885–5894.
113. Hong, Y.; Wu, J.; Zhao, J.; Wang, H.; Liu, Y.; Chen, T.; Kan, X.; Tao, Q.; Shen, X.; Yan, K.; Zhai, Z. miR-29b and miR-29c are involved in toll-like receptor control of glucocorticoid-induced apoptosis in human plasmacytoid dendritic cells. PLoS ONE 2013, 8, e69926.
114. Wang, G.; Tam, L.S.; Li, E.K.; Kwan, B.C.; Chow, K.M.; Luk, C.C.; Li, P.K.; Szeto, C.C. Serum and urinary cell-free miR-146a and miR-155 in patients with systemic lupus erythematosus. J. Rheumatol. 2010, 37, 2516–2522.
115. Wang, G.; Tam, L.S.; Li, E.K.; Kwan, B.C.; Chow, K.M.; Luk, C.C.; Li, P.K.; Szeto, C.C. Serum and urinary free microrna level in patients with systemic lupus erythematosus. Lupus 2011, 20, 493–500.
116. Wang, H.; Peng, W.; Ouyang, X.; Li, W.; Dai, Y. Circulating microRNAs as candidate biomarkers in patients with systemic lupus erythematosus. Transl. Res. J. Lab. Clin. Med. 2012, 160, 198–206.
117. Ceribelli, A.; Yao, B.; Dominguez-Gutierrez, P.R.; Chan, E.K. Lupus T cells switched on by DNA hypomethylation via microRNA? Arthritis Rheum. 2011, 63, 1177–1181.
118. Bollati, V.; Marinelli, B.; Apostoli, P.; Bonzini, M.; Nordio, F.; Hoxha, M.; Pegoraro, V.; Motta, V.; Tarantini, L.; Cantone, L., et al. Exposure to metal-rich particulate matter modifies the expression of candidate microRNAs in peripheral blood leukocytes. Environ. Health Perspect. 2010, 118, 763–768.
119. Dai, R.; Phillips, R.A.; Zhang, Y.; Khan, D.; Crasta, O.; Ahmed, S.A. Suppression of LPS-induced interferon-γ and nitric oxide in splenic lymphocytes by select estrogen-regulated microRNAs: A novel mechanism of immune modulation. Blood 2008, 112, 4591–4597.
120. Dai, Y.; Huang, Y.S.; Tang, M.; Lv, T.Y.; Hu, C.X.; Tan, Y.H.; Xu, Z.M.; Yin, Y.B. Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients. Lupus 2007, 16, 939–946.
121. Te, J.L.; Dozmorov, I.M.; Guthridge, J.M.; Nguyen, K.L.; Cavett, J.W.; Kelly, J.A.; Bruner, G.R.; Harley, J.B.; Ojwang, J.O. Identification of unique microRNA signature associated with lupus nephritis. PLoS ONE 2010, 5, e10344.
122. Luo, X.; Zhang, L.; Li, M.; Zhang, W.; Leng, X.; Zhang, F.; Zhao, Y.; Zeng, X. The role of miR-125b in T lymphocytes in the pathogenesis of systemic lupus erythematosus. Clin. Exp. Rheumatol. 2013, 31, 263–271.
123. Tang, Y.; Luo, X.; Cui, H.; Ni, X.; Yuan, M.; Guo, Y.; Huang, X.; Zhou, H.; de Vries, N.; Tak, P.P., et al. MicroRNA-146a contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum. 2009, 60, 1065–1075.
124. Lu, M.C.; Lai, N.S.; Chen, H.C.; Yu, H.C.; Huang, K.Y.; Tung, C.H.; Huang, H.B.; Yu, C.L. Decreased microRNA(miR)-145 and increased miR-224 expression in T cells from patients with systemic lupus erythematosus involved in lupus immunopathogenesis. Clin. Exp. Immunol. 2013, 171, 91–99.
125. Carlsen, A.L.; Schetter, A.J.; Nielsen, C.T.; Lood, C.; Knudsen, S.; Voss, A.; Harris, C.C.; Hellmark, T.; Segelmark, M.; Jacobsen, S., et al. Circulating microRNA expression profiles associated with systemic lupus erythematosus. Arthritis Rheum. 2013, 65, 1324–1334.
126. Lewis, E.C.; Blaabjerg, L.; Storling, J.; Ronn, S.G.; Mascagni, P.; Dinarello, C.A.; Mandrup-Poulsen, T. The oral histone deacetylase inhibitor ITF2357 reduces cytokines and protects islet β cells in vivo and in vitro. Mol. Med. 2011, 17, 369–377.
127. Nicodeme, E.; Jeffrey, K.L.; Schaefer, U.; Beinke, S.; Dewell, S.; Chung, C.W.; Chandwani, R.; Marazzi, I.; Wilson, P.; Coste, H., et al. Suppression of inflammation by a synthetic histone mimic. Nature 2010, 468, 1119–1123.
128. Salvi, V.; Bosisio, D.; Mitola, S.; Andreoli, L.; Tincani, A.; Sozzani, S. Trichostatin a blocks type I interferon production by activated plasmacytoid dendritic cells. Immunobiology 2010, 215, 756–761.
129. Regna, N.L.; Chafin, C.B.; Hammond, S.E.; Puthiyaveetil, A.G.; Caudell, D.L.; Reilly, C.M. Class I and II histone deacetylase inhibition by ITF2357 reduces SLE pathogenesis in vivo. Clin. Immunol. 2014, 151, 29–42.
130. Thai, T.H.; Patterson, H.C.; Pham, D.H.; Kis-Toth, K.; Kaminski, D.A.; Tsokos, G.C. Deletion of microRNA-155 reduces autoantibody responses and alleviates lupus-like disease in the Faslpr mouse. Proc. Natl. Acad. Sci. USA 2013, 110, 20194–20199.
131. Roadmap Epigenomics Consortium; Kundaje, A.; Meuleman, W.; Ernst, J.; Bilenky, M.; Yen, A.; Heravi-Moussavi, A.; Kheradpour, P.; Zhang, Z.; Wang, J.; Ziller, M.J., et al. Integrative analysis of 111 reference human epigenomes. Nature 2015, 518, 317–330.